Sobhani N - Search Results

1

Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer.

Sobhani N, Fassl A, Mondani G, Generali D, Otto T. Sobhani N, et al. Cells. 2021 Feb 1;10(2):293. doi: 10.3390/cells10020293. Cells. 2021. PMID: 33535617 Free PMC article. Review.

2

The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma.

Jiang N, Zheng Y, Ding J, Wang J, Zhu F, Wang M, Sobhani N, Neeli P, Wang G, Li H, Zheng J, Chai D. Jiang N, et al. Among authors: sobhani n. NPJ Vaccines. 2023 Aug 4;8(1):109. doi: 10.1038/s41541-023-00706-x. NPJ Vaccines. 2023. PMID: 37542081 Free PMC article.

3

Advances in systemic therapy for metastatic breast cancer: future perspectives.

Corona SP, Sobhani N, Ianza A, Roviello G, Mustacchi G, Bortul M, Zanconati F, Generali D. Corona SP, et al. Among authors: sobhani n. Med Oncol. 2017 Jul;34(7):119. doi: 10.1007/s12032-017-0975-5. Epub 2017 May 19. Med Oncol. 2017. PMID: 28526922 Review.

4

Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives.

Corona SP, Sobhani N, Ianza A, Roviello G, Mustacchi G, Bortul M, Zanconati F, Generali D. Corona SP, et al. Among authors: sobhani n. Med Oncol. 2017 Jul;34(7):130. doi: 10.1007/s12032-017-0989-z. Med Oncol. 2017. PMID: 28616710 No abstract available.

5

Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma.

Sobhani N, Corona SP, Zanconati F, Generali D. Sobhani N, et al. Genes Cancer. 2017 Mar;8(3-4):495-496. doi: 10.18632/genesandcancer.138. Genes Cancer. 2017. PMID: 28680533 Free PMC article.

6

PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy.

Sobhani N, Generali D, Roviello G. Sobhani N, et al. EBioMedicine. 2017 Aug;22:18-19. doi: 10.1016/j.ebiom.2017.07.003. Epub 2017 Jul 5. EBioMedicine. 2017. PMID: 28688823 Free PMC article. No abstract available.

7

Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma.

Sobhani N, Roviello G, Corona SP, Ianza A, Zanconati F, Generali D. Sobhani N, et al. Lung Cancer. 2017 Dec;114:103-105. doi: 10.1016/j.lungcan.2017.07.027. Epub 2017 Jul 24. Lung Cancer. 2017. PMID: 28757047 Free article. No abstract available.

8

Bevacizumab in small cell lung cancer.

Roviello G, Sobhani N, Generali D. Roviello G, et al. Among authors: sobhani n. Ann Transl Med. 2017 Sep;5(17):361. doi: 10.21037/atm.2017.06.44. Ann Transl Med. 2017. PMID: 28936455 Free PMC article. No abstract available.

9

Advances in systemic therapy for malignant mesothelioma: future perspectives.

Sobhani N, Corona SP, Bonazza D, Ianza A, Pivetta T, Roviello G, Cortale M, Guglielmi A, Zanconati F, Generali D. Sobhani N, et al. Future Oncol. 2017 Oct;13(23):2083-2101. doi: 10.2217/fon-2017-0224. Epub 2017 Oct 6. Future Oncol. 2017. PMID: 28984470 Review.

10

The prognostic value of PI3K mutational status in breast cancer: A meta-analysis.

Sobhani N, Roviello G, Corona SP, Scaltriti M, Ianza A, Bortul M, Zanconati F, Generali D. Sobhani N, et al. J Cell Biochem. 2018 Jun;119(6):4287-4292. doi: 10.1002/jcb.26687. Epub 2018 Mar 1. J Cell Biochem. 2018. PMID: 29345357 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters